전립선비대증 진료지침 - theprostate.org

1 The Korean Prostate Society ( ) ( ) 13.

2 7 . 2004 6 .. , .. , , , .. 2009 European Association of Urology (EAU) Guidelines .. , , , 29.

3 1. , 1-1) (01) 1-2) (07) 1-3) (12)2. 2-1) (17) 2-2) (26) 3. 3-1) (35) 3-2) (38) 5- 5- 3-3) (58) 4.

4 (75)5. (78) 11. , 1-1) (Benign Prostatic Hypeplasia: BPH) 60 40-70% (Lower Urinary Tract Symptoms: LUTS) , .. (In-ternational Prostate Symptom Score: IPSS) ,1-3 .. (benign prostatic enlargement) .. 40 (Benign Prostatic Hyperpla-sia: BPH) , (LUTS) , (urodynamic study) (Bladder Outlet Obstruction: BOO) (Fig.

5 1). (BPH), (LUTS), (BOO) , .2 Fig. 1. Diagram showing the relationship between histologic benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), benign prostatic enlargement (BPE), and bladder outlet obstruction (BOO). , , .. , 20g 33g .4 65 , 66-70 , 71-75 26g, 76-80 .5 Guess 6 / 69% .. 31) (watchful waiting cohorts) 2) - 3) (longitudinal population-based study).

6 Craigen 7 , , Barham 8 118 . Glynn 9 40 80 77% .. , , , (Prostate specific Antigen: PSA) .. (prostatism) . , , (uroflowmetry) (pressure-flow study) (bladder outlet obstruction).

7 Table 1 . Garraway 10 20g 15ml/s 20g , 40-79 40 , 50 , 60 , 70 , , 43%, . Olmsted county 60 41%, 70 45% .11 Bosch 12 30g , 8 19% , 10ml/s , 50ml 4 Table 1. Prevalence of moderate to severe lower urinary tract symptoms in community-population AuthorCountryMen with IPSS 8 (%)50-59 yrs60-69 yrs70-79 yrsChung et al2 Korea374970 Norman et al17 Canada152731 Chute et et al19 France 81427 Bosch et al12 Netherland263036 Tsukamoto et al14 Japan293156 Moon et . 50-80 30%.

8 60 36%, 70 43%, 80 53% , 42% .13 ,14,15 .16 . , , , . , , . , , , . , , , . 5 1. Lee E, Yoo KY, Kim Y, Shin Y, Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study.

9 Eur Urol 1998;33:17-212. Chung TG, Chung J, Lee MS, Ahn H. Prevalence of benign prostatic hyperplasia in Jeong-Eup area: community-based study. Korean J Urol 1999;40:52-83. Rhew HY, Koo JH, Cho SS, Kang JS, Lee CK, Kim JC, et al. The prevalence of BPH in Busan city over age 40. Korean J Urol 2001;42:223-74. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hy-perplasia with age. J Urol 1984;132:474-95. Lee H, Hwa JS, Choi BS, Choi CW, Kim JT, Jung SH, et al. Correlation between age, prostatic volume and voiding symptoms in randomly selected Korean over age 60. Korean J Urol 1994;35:1208-136. Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990;17:241-67. Craigen AA, Hickling JB, Saunders CR, Carpenter RG.

10 Natural history of prostatic obstruction. A prospective survey. J R Coll Gen Pract 1969;18:226-328. Barham CP, Pocock RD, James ED. Who needs a prostatectomy? Review of a waiting list. Br J Urol 1993;72:314-79. Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The development of benign prostatic hy-perplasia among volunteers in the Normative Aging Study. Am J Epidemiol 1985;121:78-9010. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469-7111. Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ, et al. Comparison of low-er urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology 2003;61:1086-9112. Bosch JL, Hop WC, Kirkels WJ, Schr der FH.